Global Opioids Agonist Drugs Market Research Report 2023

Global Opioids Agonist Drugs Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioids Agonist Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Codeine
1.2.3 Fentanyl
1.2.4 Meperidine
1.2.5 Methadone
1.2.6 Morphine
1.2.7 Hydrocodone
1.3 Market by Application
1.3.1 Global Opioids Agonist Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pain Management
1.3.3 Cough Treatment
1.3.4 Diarrhea Treatment
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Opioids Agonist Drugs Market Perspective (2018-2029)
2.2 Opioids Agonist Drugs Growth Trends by Region
2.2.1 Global Opioids Agonist Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Opioids Agonist Drugs Historic Market Size by Region (2018-2023)
2.2.3 Opioids Agonist Drugs Forecasted Market Size by Region (2024-2029)
2.3 Opioids Agonist Drugs Market Dynamics
2.3.1 Opioids Agonist Drugs Industry Trends
2.3.2 Opioids Agonist Drugs Market Drivers
2.3.3 Opioids Agonist Drugs Market Challenges
2.3.4 Opioids Agonist Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Opioids Agonist Drugs Players by Revenue
3.1.1 Global Top Opioids Agonist Drugs Players by Revenue (2018-2023)
3.1.2 Global Opioids Agonist Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Opioids Agonist Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Opioids Agonist Drugs Revenue
3.4 Global Opioids Agonist Drugs Market Concentration Ratio
3.4.1 Global Opioids Agonist Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioids Agonist Drugs Revenue in 2022
3.5 Opioids Agonist Drugs Key Players Head office and Area Served
3.6 Key Players Opioids Agonist Drugs Product Solution and Service
3.7 Date of Enter into Opioids Agonist Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Opioids Agonist Drugs Breakdown Data by Type
4.1 Global Opioids Agonist Drugs Historic Market Size by Type (2018-2023)
4.2 Global Opioids Agonist Drugs Forecasted Market Size by Type (2024-2029)
5 Opioids Agonist Drugs Breakdown Data by Application
5.1 Global Opioids Agonist Drugs Historic Market Size by Application (2018-2023)
5.2 Global Opioids Agonist Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Opioids Agonist Drugs Market Size (2018-2029)
6.2 North America Opioids Agonist Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Opioids Agonist Drugs Market Size by Country (2018-2023)
6.4 North America Opioids Agonist Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Opioids Agonist Drugs Market Size (2018-2029)
7.2 Europe Opioids Agonist Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Opioids Agonist Drugs Market Size by Country (2018-2023)
7.4 Europe Opioids Agonist Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Opioids Agonist Drugs Market Size (2018-2029)
8.2 Asia-Pacific Opioids Agonist Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Opioids Agonist Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Opioids Agonist Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Opioids Agonist Drugs Market Size (2018-2029)
9.2 Latin America Opioids Agonist Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Opioids Agonist Drugs Market Size by Country (2018-2023)
9.4 Latin America Opioids Agonist Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Opioids Agonist Drugs Market Size (2018-2029)
10.2 Middle East & Africa Opioids Agonist Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Opioids Agonist Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Opioids Agonist Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Purdue Pharma
11.1.1 Purdue Pharma Company Detail
11.1.2 Purdue Pharma Business Overview
11.1.3 Purdue Pharma Opioids Agonist Drugs Introduction
11.1.4 Purdue Pharma Revenue in Opioids Agonist Drugs Business (2018-2023)
11.1.5 Purdue Pharma Recent Development
11.2 Titan pharmaceuticals
11.2.1 Titan pharmaceuticals Company Detail
11.2.2 Titan pharmaceuticals Business Overview
11.2.3 Titan pharmaceuticals Opioids Agonist Drugs Introduction
11.2.4 Titan pharmaceuticals Revenue in Opioids Agonist Drugs Business (2018-2023)
11.2.5 Titan pharmaceuticals Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Opioids Agonist Drugs Introduction
11.3.4 Boehringer Ingelheim Revenue in Opioids Agonist Drugs Business (2018-2023)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Janssen Pharmaceuticals, Inc
11.4.1 Janssen Pharmaceuticals, Inc Company Detail
11.4.2 Janssen Pharmaceuticals, Inc Business Overview
11.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Introduction
11.4.4 Janssen Pharmaceuticals, Inc Revenue in Opioids Agonist Drugs Business (2018-2023)
11.4.5 Janssen Pharmaceuticals, Inc Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Opioids Agonist Drugs Introduction
11.5.4 Sanofi Revenue in Opioids Agonist Drugs Business (2018-2023)
11.5.5 Sanofi Recent Development
11.6 Sun Pharmaceuticals
11.6.1 Sun Pharmaceuticals Company Detail
11.6.2 Sun Pharmaceuticals Business Overview
11.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Introduction
11.6.4 Sun Pharmaceuticals Revenue in Opioids Agonist Drugs Business (2018-2023)
11.6.5 Sun Pharmaceuticals Recent Development
11.7 Mallinckrodt Pharmaceuticals
11.7.1 Mallinckrodt Pharmaceuticals Company Detail
11.7.2 Mallinckrodt Pharmaceuticals Business Overview
11.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Introduction
11.7.4 Mallinckrodt Pharmaceuticals Revenue in Opioids Agonist Drugs Business (2018-2023)
11.7.5 Mallinckrodt Pharmaceuticals Recent Development
11.8 Egalet Corporation
11.8.1 Egalet Corporation Company Detail
11.8.2 Egalet Corporation Business Overview
11.8.3 Egalet Corporation Opioids Agonist Drugs Introduction
11.8.4 Egalet Corporation Revenue in Opioids Agonist Drugs Business (2018-2023)
11.8.5 Egalet Corporation Recent Development
11.9 Endo Pharmaceuticals Inc.
11.9.1 Endo Pharmaceuticals Inc. Company Detail
11.9.2 Endo Pharmaceuticals Inc. Business Overview
11.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Introduction
11.9.4 Endo Pharmaceuticals Inc. Revenue in Opioids Agonist Drugs Business (2018-2023)
11.9.5 Endo Pharmaceuticals Inc. Recent Development
11.10 Allergan, Plc
11.10.1 Allergan, Plc Company Detail
11.10.2 Allergan, Plc Business Overview
11.10.3 Allergan, Plc Opioids Agonist Drugs Introduction
11.10.4 Allergan, Plc Revenue in Opioids Agonist Drugs Business (2018-2023)
11.10.5 Allergan, Plc Recent Development
11.11 Pfizer Inc
11.11.1 Pfizer Inc Company Detail
11.11.2 Pfizer Inc Business Overview
11.11.3 Pfizer Inc Opioids Agonist Drugs Introduction
11.11.4 Pfizer Inc Revenue in Opioids Agonist Drugs Business (2018-2023)
11.11.5 Pfizer Inc Recent Development
11.12 Johnson & Johnson Services, Inc.
11.12.1 Johnson & Johnson Services, Inc. Company Detail
11.12.2 Johnson & Johnson Services, Inc. Business Overview
11.12.3 Johnson & Johnson Services, Inc. Opioids Agonist Drugs Introduction
11.12.4 Johnson & Johnson Services, Inc. Revenue in Opioids Agonist Drugs Business (2018-2023)
11.12.5 Johnson & Johnson Services, Inc. Recent Development
11.13 Hikma Pharmaceuticals PLC
11.13.1 Hikma Pharmaceuticals PLC Company Detail
11.13.2 Hikma Pharmaceuticals PLC Business Overview
11.13.3 Hikma Pharmaceuticals PLC Opioids Agonist Drugs Introduction
11.13.4 Hikma Pharmaceuticals PLC Revenue in Opioids Agonist Drugs Business (2018-2023)
11.13.5 Hikma Pharmaceuticals PLC Recent Development
11.14 Grünenthal
11.14.1 Grünenthal Company Detail
11.14.2 Grünenthal Business Overview
11.14.3 Grünenthal Opioids Agonist Drugs Introduction
11.14.4 Grünenthal Revenue in Opioids Agonist Drugs Business (2018-2023)
11.14.5 Grünenthal Recent Development
11.15 AbbVie Inc.
11.15.1 AbbVie Inc. Company Detail
11.15.2 AbbVie Inc. Business Overview
11.15.3 AbbVie Inc. Opioids Agonist Drugs Introduction
11.15.4 AbbVie Inc. Revenue in Opioids Agonist Drugs Business (2018-2023)
11.15.5 AbbVie Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Opioids Agonist Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Codeine
Table 3. Key Players of Fentanyl
Table 4. Key Players of Meperidine
Table 5. Key Players of Methadone
Table 6. Key Players of Morphine
Table 7. Key Players of Hydrocodone
Table 8. Global Opioids Agonist Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Opioids Agonist Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Opioids Agonist Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Opioids Agonist Drugs Market Share by Region (2018-2023)
Table 12. Global Opioids Agonist Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global Opioids Agonist Drugs Market Share by Region (2024-2029)
Table 14. Opioids Agonist Drugs Market Trends
Table 15. Opioids Agonist Drugs Market Drivers
Table 16. Opioids Agonist Drugs Market Challenges
Table 17. Opioids Agonist Drugs Market Restraints
Table 18. Global Opioids Agonist Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Opioids Agonist Drugs Market Share by Players (2018-2023)
Table 20. Global Top Opioids Agonist Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids Agonist Drugs as of 2022)
Table 21. Ranking of Global Top Opioids Agonist Drugs Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Opioids Agonist Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Opioids Agonist Drugs Product Solution and Service
Table 25. Date of Enter into Opioids Agonist Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Opioids Agonist Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Opioids Agonist Drugs Revenue Market Share by Type (2018-2023)
Table 29. Global Opioids Agonist Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global Opioids Agonist Drugs Revenue Market Share by Type (2024-2029)
Table 31. Global Opioids Agonist Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Opioids Agonist Drugs Revenue Market Share by Application (2018-2023)
Table 33. Global Opioids Agonist Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 34. Global Opioids Agonist Drugs Revenue Market Share by Application (2024-2029)
Table 35. North America Opioids Agonist Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Opioids Agonist Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Opioids Agonist Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Opioids Agonist Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. Europe Opioids Agonist Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Opioids Agonist Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 41. Asia-Pacific Opioids Agonist Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Asia-Pacific Opioids Agonist Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Opioids Agonist Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 44. Latin America Opioids Agonist Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Latin America Opioids Agonist Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Opioids Agonist Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 47. Middle East & Africa Opioids Agonist Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Middle East & Africa Opioids Agonist Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Opioids Agonist Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 50. Purdue Pharma Company Detail
Table 51. Purdue Pharma Business Overview
Table 52. Purdue Pharma Opioids Agonist Drugs Product
Table 53. Purdue Pharma Revenue in Opioids Agonist Drugs Business (2018-2023) & (US$ Million)
Table 54. Purdue Pharma Recent Development
Table 55. Titan pharmaceuticals Company Detail
Table 56. Titan pharmaceuticals Business Overview
Table 57. Titan pharmaceuticals Opioids Agonist Drugs Product
Table 58. Titan pharmaceuticals Revenue in Opioids Agonist Drugs Business (2018-2023) & (US$ Million)
Table 59. Titan pharmaceuticals Recent Development
Table 60. Boehringer Ingelheim Company Detail
Table 61. Boehringer Ingelheim Business Overview
Table 62. Boehringer Ingelheim Opioids Agonist Drugs Product
Table 63. Boehringer Ingelheim Revenue in Opioids Agonist Drugs Business (2018-2023) & (US$ Million)
Table 64. Boehringer Ingelheim Recent Development
Table 65. Janssen Pharmaceuticals, Inc Company Detail
Table 66. Janssen Pharmaceuticals, Inc Business Overview
Table 67. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product
Table 68. Janssen Pharmaceuticals, Inc Revenue in Opioids Agonist Drugs Business (2018-2023) & (US$ Million)
Table 69. Janssen Pharmaceuticals, Inc Recent Development
Table 70. Sanofi Company Detail
Table 71. Sanofi Business Overview
Table 72. Sanofi Opioids Agonist Drugs Product
Table 73. Sanofi Revenue in Opioids Agonist Drugs Business (2018-2023) & (US$ Million)
Table 74. Sanofi Recent Development
Table 75. Sun Pharmaceuticals Company Detail
Table 76. Sun Pharmaceuticals Business Overview
Table 77. Sun Pharmaceuticals Opioids Agonist Drugs Product
Table 78. Sun Pharmaceuticals Revenue in Opioids Agonist Drugs Business (2018-2023) & (US$ Million)
Table 79. Sun Pharmaceuticals Recent Development
Table 80. Mallinckrodt Pharmaceuticals Company Detail
Table 81. Mallinckrodt Pharmaceuticals Business Overview
Table 82. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product
Table 83. Mallinckrodt Pharmaceuticals Revenue in Opioids Agonist Drugs Business (2018-2023) & (US$ Million)
Table 84. Mallinckrodt Pharmaceuticals Recent Development
Table 85. Egalet Corporation Company Detail
Table 86. Egalet Corporation Business Overview
Table 87. Egalet Corporation Opioids Agonist Drugs Product
Table 88. Egalet Corporation Revenue in Opioids Agonist Drugs Business (2018-2023) & (US$ Million)
Table 89. Egalet Corporation Recent Development
Table 90. Endo Pharmaceuticals Inc. Company Detail
Table 91. Endo Pharmaceuticals Inc. Business Overview
Table 92. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product
Table 93. Endo Pharmaceuticals Inc. Revenue in Opioids Agonist Drugs Business (2018-2023) & (US$ Million)
Table 94. Endo Pharmaceuticals Inc. Recent Development
Table 95. Allergan, Plc Company Detail
Table 96. Allergan, Plc Business Overview
Table 97. Allergan, Plc Opioids Agonist Drugs Product
Table 98. Allergan, Plc Revenue in Opioids Agonist Drugs Business (2018-2023) & (US$ Million)
Table 99. Allergan, Plc Recent Development
Table 100. Pfizer Inc Company Detail
Table 101. Pfizer Inc Business Overview
Table 102. Pfizer Inc Opioids Agonist Drugs Product
Table 103. Pfizer Inc Revenue in Opioids Agonist Drugs Business (2018-2023) & (US$ Million)
Table 104. Pfizer Inc Recent Development
Table 105. Johnson & Johnson Services, Inc. Company Detail
Table 106. Johnson & Johnson Services, Inc. Business Overview
Table 107. Johnson & Johnson Services, Inc. Opioids Agonist Drugs Product
Table 108. Johnson & Johnson Services, Inc. Revenue in Opioids Agonist Drugs Business (2018-2023) & (US$ Million)
Table 109. Johnson & Johnson Services, Inc. Recent Development
Table 110. Hikma Pharmaceuticals PLC Company Detail
Table 111. Hikma Pharmaceuticals PLC Business Overview
Table 112. Hikma Pharmaceuticals PLC Opioids Agonist Drugs Product
Table 113. Hikma Pharmaceuticals PLC Revenue in Opioids Agonist Drugs Business (2018-2023) & (US$ Million)
Table 114. Hikma Pharmaceuticals PLC Recent Development
Table 115. Grünenthal Company Detail
Table 116. Grünenthal Business Overview
Table 117. Grünenthal Opioids Agonist Drugs Product
Table 118. Grünenthal Revenue in Opioids Agonist Drugs Business (2018-2023) & (US$ Million)
Table 119. Grünenthal Recent Development
Table 120. AbbVie Inc. Company Detail
Table 121. AbbVie Inc. Business Overview
Table 122. AbbVie Inc. Opioids Agonist Drugs Product
Table 123. AbbVie Inc. Revenue in Opioids Agonist Drugs Business (2018-2023) & (US$ Million)
Table 124. AbbVie Inc. Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Opioids Agonist Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Opioids Agonist Drugs Market Share by Type: 2022 VS 2029
Figure 3. Codeine Features
Figure 4. Fentanyl Features
Figure 5. Meperidine Features
Figure 6. Methadone Features
Figure 7. Morphine Features
Figure 8. Hydrocodone Features
Figure 9. Global Opioids Agonist Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Opioids Agonist Drugs Market Share by Application: 2022 VS 2029
Figure 11. Pain Management Case Studies
Figure 12. Cough Treatment Case Studies
Figure 13. Diarrhea Treatment Case Studies
Figure 14. Opioids Agonist Drugs Report Years Considered
Figure 15. Global Opioids Agonist Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Opioids Agonist Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Opioids Agonist Drugs Market Share by Region: 2022 VS 2029
Figure 18. Global Opioids Agonist Drugs Market Share by Players in 2022
Figure 19. Global Top Opioids Agonist Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids Agonist Drugs as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Opioids Agonist Drugs Revenue in 2022
Figure 21. North America Opioids Agonist Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Opioids Agonist Drugs Market Share by Country (2018-2029)
Figure 23. United States Opioids Agonist Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Opioids Agonist Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Opioids Agonist Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Opioids Agonist Drugs Market Share by Country (2018-2029)
Figure 27. Germany Opioids Agonist Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Opioids Agonist Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Opioids Agonist Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Opioids Agonist Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Opioids Agonist Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Opioids Agonist Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Opioids Agonist Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Opioids Agonist Drugs Market Share by Region (2018-2029)
Figure 35. China Opioids Agonist Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Opioids Agonist Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Opioids Agonist Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Opioids Agonist Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Opioids Agonist Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Opioids Agonist Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Opioids Agonist Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Opioids Agonist Drugs Market Share by Country (2018-2029)
Figure 43. Mexico Opioids Agonist Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Opioids Agonist Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Opioids Agonist Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Opioids Agonist Drugs Market Share by Country (2018-2029)
Figure 47. Turkey Opioids Agonist Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Opioids Agonist Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Purdue Pharma Revenue Growth Rate in Opioids Agonist Drugs Business (2018-2023)
Figure 50. Titan pharmaceuticals Revenue Growth Rate in Opioids Agonist Drugs Business (2018-2023)
Figure 51. Boehringer Ingelheim Revenue Growth Rate in Opioids Agonist Drugs Business (2018-2023)
Figure 52. Janssen Pharmaceuticals, Inc Revenue Growth Rate in Opioids Agonist Drugs Business (2018-2023)
Figure 53. Sanofi Revenue Growth Rate in Opioids Agonist Drugs Business (2018-2023)
Figure 54. Sun Pharmaceuticals Revenue Growth Rate in Opioids Agonist Drugs Business (2018-2023)
Figure 55. Mallinckrodt Pharmaceuticals Revenue Growth Rate in Opioids Agonist Drugs Business (2018-2023)
Figure 56. Egalet Corporation Revenue Growth Rate in Opioids Agonist Drugs Business (2018-2023)
Figure 57. Endo Pharmaceuticals Inc. Revenue Growth Rate in Opioids Agonist Drugs Business (2018-2023)
Figure 58. Allergan, Plc Revenue Growth Rate in Opioids Agonist Drugs Business (2018-2023)
Figure 59. Pfizer Inc Revenue Growth Rate in Opioids Agonist Drugs Business (2018-2023)
Figure 60. Johnson & Johnson Services, Inc. Revenue Growth Rate in Opioids Agonist Drugs Business (2018-2023)
Figure 61. Hikma Pharmaceuticals PLC Revenue Growth Rate in Opioids Agonist Drugs Business (2018-2023)
Figure 62. Grünenthal Revenue Growth Rate in Opioids Agonist Drugs Business (2018-2023)
Figure 63. AbbVie Inc. Revenue Growth Rate in Opioids Agonist Drugs Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs